• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITHS HEALTHCARE MANUFACTURING S.A. DE C.V. CADD ADMINISTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITHS HEALTHCARE MANUFACTURING S.A. DE C.V. CADD ADMINISTRATION SET; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Catalog Number 21-7022-24
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/14/2025
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that there was a defect/error with a cadd administration set that lead to chemotherapy leaking prior to administration.The pharmacy staff reviewed two additional cadd administration sets and the same thing happened to those - that the tubing separates from the plastic base quite easily, which could result in leakage.The event occurred prior to administration.It is unknown if the product is available for investigation.There was no patient involvement, and no patient harm/adverse event reported.
 
Additional Manufacturer Narrative
Three photos were reviewed for the device evaluation.The reported problem was unable to be confirmed.A device history record (dhr) review was conducted which indicated all inspections were completed and no issues were noted during manufacture.
 
Additional Manufacturer Narrative
D9: 13-feb-2025.H3: one used administration set from lot number 6026702 was received for evaluation.As received, the tubing was observed to be separated from the housing on the outgoing side.Inspection of the area showed evidence of solvent on both the tube and the cassette.Functional testing was not able to duplicate the reported issue.No leakage was observed during any functional tests.The device tested normally.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CADD ADMINISTRATION SET
Common Device Name
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
SMITHS HEALTHCARE MANUFACTURING S.A. DE C.V.
ave calidad no. 4, parque
tijuana
MX 
Manufacturer Contact
reed covert
6000 nathan ln n
minneapolis, MN 55442
2247062300
MDR Report Key21337207
Report Number3012307300-2025-01628
Device Sequence Number8459250
Product Code FPA
UDI-Device Identifier10610586019791
UDI-Public(01)10610586019791(17)290713(10)6026702
Combination Product (Y/N)N
Initial Reporter StateAZ
Initial Reporter CountryUS
PMA/510(K) Number
K895046
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,User Facility
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 08/08/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number21-7022-24
Device Lot Number6026702
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/15/2025
Supplement Date Received by Manufacturer03/28/2025
Initial Report FDA Received Date02/07/2025
Supplement Report FDA Received Date08/08/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/25/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-